Auszug
Über die Gehirn-Darm-Achse (Brain-Gut-Axis) hat der Gastrointestinaltrakt eine besonders enge Verbindung mit unserer Psyche. Dies spiegelt sich auch auf klinischer Ebene wieder, da gastroenterologische und psychische Störungen häufig gemeinsam auftreten. Es besteht daher die Notwendigkeit Psychiatrie, Psychotherapie und Gastroenterologie „zusammenzubringen“. Die Kenntnis und der Umgang mit Psychopharmaka spielt daher im Rahmen gastroenterologischer Störungen für den Kliniker eine wichtige Rolle. Insbesondere werden Antidepressiva in der Therapie funktioneller gastrointestinaler Störungen eingesetzt.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Aigner M und Lenz G (2006) Kognition — Emotion — Verhalten: Die Entstehung psychischer Probleme aus der Sicht der Verhaltenstherapie. In: Springer M, Löffler-Staska H, Kopeinig-Kreissl M (Hrsg) Psychische Funktionen in Gesundheit und Krankheit, 3. Aufl. Facultas, Wien, S 44–53
Bonaz B (2003) Visceral sensitivity perturbation integration in the brain-gut axis in functional digestive disorders. J Physiol Pharmacol 54[Suppl 4]: 27–42
Brambilla P, Cipriani A, Hotopf M, Barbui C (2005) Side-effect profile of fluoxetine in comparison with other SSRIs, tricyclic and newer antidepressants: A meta-analysis of clinical trial data. Pharmacppsychiatry 38: 69–77
Bratman S, Knight D (2000) Health food junkies: Orthorexia nervosa — the health food eating disorder. Random House, New York
Budavari AI, Olden KW (2003) Psychosocial aspects of functional gastrointestinal disorders. Gastroenterol Clin North Am 32: 477–506
Büttner M, Walder B, von Elm E, Tramer MR (2004) Is low-dose haloperidol a useful antiemetic? A meta-analysis of published and unpublished randomised trials. Anesthesiology 101: 1454–1463
Birks J (2006) Cholinesterase inhibitors for Alzheimer’s disease. Cochrane Database of Systematic Reviews, Issue 1. Art. No.: CD005593. DOI: 10.1002/14651858.CD005593
Clouse RE, Lustman PJ (2005) Use of psychopharmacological agents for functional gastrointestinal disorders. Gut 54: 1332–1341
Cole MG, Primeau FJ (1993) Prognosis of delirium in elderly hospital patients. CMAJ 149: 41–46
Damasio AR (1994) Descates’ Irrtum. Fühlen, Denken und das menschliche Gehirn. List Verlag, München, Leipzig
Delagarza VW (2003) Pharmacologic treatment of Alzheimer’s disease: an update. Am Fam Physician 68: 1365–1372
De Zwaan M (2001): Binge eating disorder and obesity. Int J Obes Relat Metab Disord [Suppl 1] 25: 51–55
Dilling H, Mombour W, Schmidt MH (Hrsg) (1993) Internationale Klassifikation psychischer Störungen. Verlag Hans Huber, Bern, Göttingen
Fullwood A, Drossman DA (1995) The relationship of psychiatric illness with gastrointestinal disease. Annu Rev Med 46: 483–496
Hergovich N, Aigner M, Eichler HG, Entlicher J, Drucker C, Jilma B (2000) Paroxetine decreases platelet serotonin storage and platelet function in human beings. Clinical Pharmacology and Therapeutics 68: 435–442
Holtmann G (2001) Therapie der funktionellen Dsypepsie (Reizmagensyndrom). Internist 42: 1261–1269
Jackson J, Fiddler M, Kapur N, Wells A, Tomenson B, Creed F (2006) Number of bodily symptoms predicts outcome more accurately than health anxiety in patients attending neurology, cardiology, and gastroenterology clinics. Journal of Psychosomatic Research 60: 357–363
Jackson JL, O’Malley PG, Tomkins G, Balden E, Santoro J, Kroenke K (2000) Treatment of functional gastrointestinal disorders with antidepressant medications: A meta-analysis. Am J Med 108: 65–72
Konturek SJ, Konturek JW, Pawlik T, Brzozowski T (2004) Brain-gut axis and its role in the control of food intake. J Physiol Pharmacol 55: 137–154
Kruse J, Wöller W (2004) Kapitel 9: Verdauungstrakt. In: Tress, Kruse Ott (Hrsg) Psychosomatische Grundversorgung. Schattauer Verlag, Stuttgart
Leserman J (2005) Sexual abuse history: prevalence, health effects, mediators, and psychological treatment. Psychosom Med 67: 906–915
Ma B, von Wasielewski R, Lindenmaier W, Dittmar KEJ (2007) Immmunohistochemical study of the blood and lymphatic vasculature and the innervation of mouse gut and gut-associated lymphoid tissue. Anatomia, Histologia, embryologia. J Veterinary Medicine Series C 36: 62–74
North CS, Downs D, Clouse RE, Alrakawi A, Dokucu ME, Cox J, Spitznagel EL, Alpers DH (2004) The presentation of irritable bowel syndrome in the context of somatization disorder. Clin Gastroenterol Hepatol 2: 787–795
Olden KW und Drossman DA (2000) Psychologic and psychiatric aspects of gastrointestinal disease. Med Clin North Am 84: 1313–1327
Rudolf G, Henningsen P, Hartkamp N, Loew T, Sack M, Scheidt CE (2001) AWMF-Leitlinie: Somatoforme Störungen. www.uni-duesseldorf.de/WWW/AWMF/ll/index.html
Rüegg JC (2006) Gehirn, Psyche Körper. Schattauer Verlag, Stuttgart
Schäfer M (2005) Häufigkeit, Ursachen, Risikofaktoren und Therapiemöglichkeiten Interferon-alpha assoziierter Depressionen. www.diss.fu-berlin.de/2005/144/
Schoniger-Hekele M, Muller C, Kutilek M, Oesterreicher C, Ferenci P, Gangl A (2000) Hepatocellular carcinoma in Austria: aetiological and clinical characteristics at presentation. Eur J Gastroenterol Hepatol 12: 941–948
Solmaz M, Kavuk I, Sayar K (2003) Psychological factors in the irritable bowel syndrome. Eur J Med Res 8: 549–556
Stern JM (2003) Review article: psychiatry, psychotherapy and gastroenterology — bringing it all together. Aliment Pharmacol Ther 17: 175–184
Szigethy E, Levy-Warren A, Whitton S, Bousvaros A, Gauvreau K, Leichtner AM, Beardslee WR (2004) Depressive symptoms and inflammatory bowel disease in children and adolescents: A cross-sectional study. J Peditr Gastroenterol Nutr 39: 395–403
Waddell TS, Hislop WS (2003) Analysis of alcoholrelated admissions in gastroenterology, cardiology and respiratory medicine. Scott Med J 48: 114–116
Wittchen HU und Jacobi F (2005) Size and burden of mental disorders in Europe — a critical review and appraisal of 27 studies. European Neuropsychopharmacology 15: 357–376
Yuan Y, Tsoi K, Hunt RH (2006) Selective serotonin reuptake inhibitors and risk of upper gi bleeding: Confusion or confounding? The American Journal of Medicine 119: 719–727
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag/Wien
About this chapter
Cite this chapter
Aigner, M., Sachs, G. (2007). Diagnostik psychischer Störungen und psychopharmakologische Therapie im klinischen Alltag. In: Moser, G. (eds) Psychosomatik in der Gastroenterologie und Hepatologie. Springer, Vienna. https://doi.org/10.1007/978-3-211-69159-5_24
Download citation
DOI: https://doi.org/10.1007/978-3-211-69159-5_24
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-69158-8
Online ISBN: 978-3-211-69159-5
eBook Packages: Medicine (German Language)